Neuro Stimulation Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL NEURO STIMULATION DEVICES INDUSTRY

2.1 Summary about Neuro Stimulation Devices Industry

2.2 Neuro Stimulation Devices Market Trends

2.2.1 Neuro Stimulation Devices Production & Consumption Trends

2.2.2 Neuro Stimulation Devices Demand Structure Trends

2.3 Neuro Stimulation Devices Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 DBS (Deep-Brain Stimulation)

4.2.2 VNS (Vagus Nerve Stimulation)

4.2.3 RNS (Responsive Neuro Stimulation)

4.2.4 TMS (Transcranial Magnetic Stimulation)

4.2.5 SCS (Spinal Cord Stimulation)

4.2.6 PNS (Peripheral Nerve Stimulation)

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Pain Management

4.3.2 Parkinson?S Disease

4.3.3 Urinary and Fecal Incontinence

4.3.4 Epilepsy

4.3.5 Hearing Loss

4.3.6 Gastroparesis

4.3.7 Depression

4.3.8 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 DBS (Deep-Brain Stimulation)

5.2.2 VNS (Vagus Nerve Stimulation)

5.2.3 RNS (Responsive Neuro Stimulation)

5.2.4 TMS (Transcranial Magnetic Stimulation)

5.2.5 SCS (Spinal Cord Stimulation)

5.2.6 PNS (Peripheral Nerve Stimulation)

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Pain Management

5.3.2 Parkinson?S Disease

5.3.3 Urinary and Fecal Incontinence

5.3.4 Epilepsy

5.3.5 Hearing Loss

5.3.6 Gastroparesis

5.3.7 Depression

5.3.8 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 DBS (Deep-Brain Stimulation)

6.2.2 VNS (Vagus Nerve Stimulation)

6.2.3 RNS (Responsive Neuro Stimulation)

6.2.4 TMS (Transcranial Magnetic Stimulation)

6.2.5 SCS (Spinal Cord Stimulation)

6.2.6 PNS (Peripheral Nerve Stimulation)

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Pain Management

6.3.2 Parkinson?S Disease

6.3.3 Urinary and Fecal Incontinence

6.3.4 Epilepsy

6.3.5 Hearing Loss

6.3.6 Gastroparesis

6.3.7 Depression

6.3.8 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 DBS (Deep-Brain Stimulation)

7.2.2 VNS (Vagus Nerve Stimulation)

7.2.3 RNS (Responsive Neuro Stimulation)

7.2.4 TMS (Transcranial Magnetic Stimulation)

7.2.5 SCS (Spinal Cord Stimulation)

7.2.6 PNS (Peripheral Nerve Stimulation)

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Pain Management

7.3.2 Parkinson?S Disease

7.3.3 Urinary and Fecal Incontinence

7.3.4 Epilepsy

7.3.5 Hearing Loss

7.3.6 Gastroparesis

7.3.7 Depression

7.3.8 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 DBS (Deep-Brain Stimulation)

8.2.2 VNS (Vagus Nerve Stimulation)

8.2.3 RNS (Responsive Neuro Stimulation)

8.2.4 TMS (Transcranial Magnetic Stimulation)

8.2.5 SCS (Spinal Cord Stimulation)

8.2.6 PNS (Peripheral Nerve Stimulation)

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Pain Management

8.3.2 Parkinson?S Disease

8.3.3 Urinary and Fecal Incontinence

8.3.4 Epilepsy

8.3.5 Hearing Loss

8.3.6 Gastroparesis

8.3.7 Depression

8.3.8 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 DBS (Deep-Brain Stimulation)

9.2.2 VNS (Vagus Nerve Stimulation)

9.2.3 RNS (Responsive Neuro Stimulation)

9.2.4 TMS (Transcranial Magnetic Stimulation)

9.2.5 SCS (Spinal Cord Stimulation)

9.2.6 PNS (Peripheral Nerve Stimulation)

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Pain Management

9.3.2 Parkinson?S Disease

9.3.3 Urinary and Fecal Incontinence

9.3.4 Epilepsy

9.3.5 Hearing Loss

9.3.6 Gastroparesis

9.3.7 Depression

9.3.8 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Medtronic (U.S)

10.1.2 St. Jude Medical (U.S)

10.1.3 Boston Scientific (U.S)

10.1.4 Cyberonics (U.S)

10.1.5 Cochlear (Australia)

10.1.6 NDI Medical (U.S)

10.1.7 NeuroPace (U.S)

10.1.8 ElectroCore Medical (U.S)

10.1.9 MED-EL (U.S)

10.1.10 Neuronetics (U.S)

10.2 Neuro Stimulation Devices Sales Date of Major Players (2017-2020e)

10.2.1 Medtronic (U.S)

10.2.2 St. Jude Medical (U.S)

10.2.3 Boston Scientific (U.S)

10.2.4 Cyberonics (U.S)

10.2.5 Cochlear (Australia)

10.2.6 NDI Medical (U.S)

10.2.7 NeuroPace (U.S)

10.2.8 ElectroCore Medical (U.S)

10.2.9 MED-EL (U.S)

10.2.10 Neuronetics (U.S)

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Neuro Stimulation Devices Product Type Overview

Table Neuro Stimulation Devices Product Type Market Share List

Table Neuro Stimulation Devices Product Type of Major Players

Table Brief Introduction of Medtronic (U.S)

Table Brief Introduction of St. Jude Medical (U.S)

Table Brief Introduction of Boston Scientific (U.S)

Table Brief Introduction of Cyberonics (U.S)

Table Brief Introduction of Cochlear (Australia)

Table Brief Introduction of NDI Medical (U.S)

Table Brief Introduction of NeuroPace (U.S)

Table Brief Introduction of ElectroCore Medical (U.S)

Table Brief Introduction of MED-EL (U.S)

Table Brief Introduction of Neuronetics (U.S)

Table Products & Services of Medtronic (U.S)

Table Products & Services of St. Jude Medical (U.S)

Table Products & Services of Boston Scientific (U.S)

Table Products & Services of Cyberonics (U.S)

Table Products & Services of Cochlear (Australia)

Table Products & Services of NDI Medical (U.S)

Table Products & Services of NeuroPace (U.S)

Table Products & Services of ElectroCore Medical (U.S)

Table Products & Services of MED-EL (U.S)

Table Products & Services of Neuronetics (U.S)

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Neuro Stimulation Devices Market Forecast (Million USD) by Region 2021f-2026f

Table Global Neuro Stimulation Devices Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Neuro Stimulation Devices Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Neuro Stimulation Devices Market Forecast (Million USD) Share by Demand 2021f-2026f